Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience - Wikidata - awgldk - TriplyDB

Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience

Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience

http://www.wikidata.org/entity/Q36461753

about

The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice.Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders.Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database Triheptanoin: A Rescue Therapy for Cardiogenic Shock in Carnitine-acylcarnitine Translocase Deficiency.Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial.Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof

P2860

Q38809233-47B5E923-2175-4924-AA4F-F6AA6E91159B Q38851664-5722ECC6-4A38-4522-9AAC-451D42EAF5EE Q39155672-AE1206DA-4088-43E0-A885-8D1D8EE4B5A5 Q39426415-65AD8654-940D-43EB-85D1-75C8226B9ADB Q42109975-163C80FE-5FB0-48F5-B659-4FDEC8A5837F Q47839385-74C2637F-3FCB-4A05-A7A2-4BE2EA7AEBF8 Q47856624-53F70B4C-8ADE-4F39-B2ED-126FD5802826 Q58780938-DCCA71F2-2DF8-4E06-AB3E-37A9278ECDCD

P2860

Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience

http://www.wikidata.org/entity/Q36461753

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Anaplerotic treatment of long- ...... Review of 15 years Experience

@ast

Anaplerotic treatment of long- ...... Review of 15 years Experience

@en

type

label

Anaplerotic treatment of long- ...... Review of 15 years Experience

@ast

Anaplerotic treatment of long- ...... Review of 15 years Experience

@en

prefLabel

Anaplerotic treatment of long- ...... Review of 15 years Experience

@ast

Anaplerotic treatment of long- ...... Review of 15 years Experience

@en

P1433

Q36461753-6A1055A6-2442-44DD-B370-07F5A5A8FCFD

P1476

Q36461753-807AE3F4-4957-4D41-87EF-CE404F1D2939

P2093

Q36461753-46D1DC36-4408-4D0E-A375-781190FCDEEB

Q36461753-8B2A2A2A-26A2-4DDF-8757-7C8B08DE23F3

P2860

Q36461753-0CD5E203-167D-412A-97BC-70F97E00525D

Q36461753-18082CCE-40AE-475A-ADF0-0A4B2F864486

Q36461753-1B5F3725-1A47-491C-B16C-57B330841532

Q36461753-1CC4275B-B7AA-4E81-94E4-20A8424EFF3D

Q36461753-2914E253-1922-4107-ABDD-51A6A160CDA1

Q36461753-2C516F0B-1CF8-4BDD-8E49-A40643D46B34

Q36461753-3ED53DFB-2B77-4251-855D-35F2D4E3892B

Q36461753-5DA56753-62D6-46BF-82D5-BF7D0672F5B9

Q36461753-5F878FDF-FC1A-42FA-A79F-8E90E71946A2

Q36461753-682C088F-F8A8-4097-ABB9-67948E2E2651

P304

Q36461753-718572FB-7A51-475A-84E4-143E7C56A987

P31

Q36461753-0850DB8A-8ED3-464C-8D45-2E484D4C5D1A

P356

Q36461753-751BC9E7-3059-4772-95AE-2D8B58501174

P433

Q36461753-BEB53F4C-37DA-4FE1-AD04-1CE9EE52964F

P478

Q36461753-1A4D4665-14F2-4CDE-AEB3-AF610CEC90C0

P577

Q36461753-79B5FF55-0DA8-402E-BB83-D2CC75E796D5

P698

Q36461753-1A4F5921-C926-451F-AEB0-80C43523462A

P932

Q36461753-6E6B4D23-6CD6-4B99-92FC-BA7A9706F820

P356

J.YMGME.2015.10.005

P1433

Molecular Genetics and Metabolism

P1476

Anaplerotic treatment of long- ...... Review of 15 years Experience

@en

P2093

Charles R Roe

http://www.w3.org/2001/XMLSchema#string

Henri Brunengraber

http://www.w3.org/2001/XMLSchema#string

P2860

Creatine and creatinine metabolism

Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice

Myocardial energy shortage and unmet anaplerotic needs in the fasted long-chain acyl-CoA dehydrogenase knockout mouse

Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry

AMPK: a nutrient and energy sensor that maintains energy homeostasis

Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.

Recognition and management of fatty acid oxidation defects: a series of 107 patients.

High rates of superoxide production in skeletal-muscle mitochondria respiring on both complex I- and complex II-linked substrates.

Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride

Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement

P304

260-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2015.10.005

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26547562

http://www.w3.org/2001/XMLSchema#string

P932

4712637

http://www.w3.org/2001/XMLSchema#string